The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
intercell | 343 |
valneva austria | 80 |
intercell usa | 24 |
intercell austria | 12 |
intercell biomedizinische forschun… 🛈 | 8 |
cytos biotechnology | 3 |
intercell ag, wien | 2 |
novartis | 2 |
intersell | 1 |
elatos | 1 |
intercell | 59 |
cytos biotechnology | 1 |
valneva austria | 12 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
isolated polypeptide of the toxin a and toxin b proteins of c. difficile and uses thereof | 31 | 2010 |
streptococcus pyogenes antigens | 27 | 2003 |
a method for identification, isolation and production of antigens to a specific pathogen | 26 | 2001 |
aluminium compounds for use in therapeutics and vaccines | 20 | 2011 |
s. pneumoniae antigens | 20 | 2003 |
small streptococcus pyogenes antigens and their use | 19 | 2006 |
improved vaccines | 18 | 2003 |
streptococcus agalactiae antigens i + ii | 17 | 2003 |
protective proteins of s. agalactiae, combinations thereof and methods of using the same | 17 | 2007 |
immunostimulatory oligodeoxynucleotides | 16 | 2000 |